Doctor Quits Safety Panel Reviewing Johnson & Johnson Uterine Device Over Conflict
Published: Jul 14, 2014
SILVER SPRING, Md.--A member of an independent panel weighing the safety of a medical device that can spread cancer in women stepped down after the U.S. Food and Drug Administration reviewed consulting fees he had accepted from a device manufacturer, the agency said Thursday.
San Francisco gynecologist Andrew Brill removed himself from the 16-member panel before two days of hearings on the device were set to begin Thursday, an FDA spokesman said. Dr. Brill didn't respond to requests for comment.
Help employers find you! Check out all the jobs and post your resume.